Browsing by Author Kweon, YO

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 2 to 8 of 8 < previous 
TitleAuthor(s)Issue DateViews
 
Phase 2a, randomized, double-blind, placebo-controlled study of an antisense inhibitor (ISIS 505358) in treatment-naïve chronic hepatitis B (CHB) patients: safety and antiviral efficacy
Proceeding/Conference:Hepatology
Yuen, RMFHeo, JJang, JWYoon, JHKweon, YOPark, SJBennett, CFKwoh, TJ
2019
8
 
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B
Journal:Gut
Lai, CLAhn, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NHKweon, YOSohn, JHLee, JKim, JAHan, KHYuen, RMF
2013
137
 
Results after 12 weeks treatment of multiple doses of GSK3389404 in chronic hepatitis B (CHB) subjects on stable nucleos(t)ide therapy in a phase 2a double-blind, placebo-controlled study
Proceeding/Conference:Hepatology
Yuen, RMFHeo, JKumada, HSuzuki, FSuzuki, YXie, QJia, JDKarino, YHou, JLChayama, KImamura, Mlao-Tan, JYLim, SGTanaka, YXie, WYoon, JHDuan, ZPKurosaki, MPark, SJLabio, EKumar, RKweon, YOYim, HJCremer, JElston, RChen, SGDavies, MBaptiste-Brown, SHan, KCampbell, FPaff, MTheodore, D
2019
10
 
Telbivudine combination with adefovir versus adefovir monotherapy in HBeAg-positive chronic hepatitis B (CHB) patients with lamivudine resistance
Proceeding/Conference:Hepatology International
Ahn, SHKweon, YOPaik, SWSohn, JHLee, KSKim, DJPiratvisuth, TYuen, RMFTrylesinski, AAvila, C
2010
50
 
Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
Journal:Hepatology International
Ahn, SHKweon, YOPaik, SWSohn, JHLee, KSKim, DJPiratvisuth, TYuen, MFChutaputti, AChao, YCTrylesinski, AAvila, C
2012
163
 
Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre study
Journal:Journal of Hepatology
Yuen, RMFAhn, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NHKweon, YOSohn, JHLee, JKim, JALai, CLHan, KH
2015
88
 
Week 48 analysis of a Phase IIB study of the efficacy and safety of LB80380 vs. entecavir in treatment-naive patients with chronic Hepatitis B
Proceeding/Conference:Hepatology
Lai, CLAhh, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NHKweon, YOSohn, JHLee, JKim, JAHan, KHYuen, MF
2011
56
Showing results 2 to 8 of 8 < previous